AR230047A1 - Procedimiento para obtener derivados heterociclicos de amidoximas - Google Patents

Procedimiento para obtener derivados heterociclicos de amidoximas

Info

Publication number
AR230047A1
AR230047A1 AR289500A AR28950082A AR230047A1 AR 230047 A1 AR230047 A1 AR 230047A1 AR 289500 A AR289500 A AR 289500A AR 28950082 A AR28950082 A AR 28950082A AR 230047 A1 AR230047 A1 AR 230047A1
Authority
AR
Argentina
Prior art keywords
amidoximes
hero
procedure
obtaining
cyclic derivatives
Prior art date
Application number
AR289500A
Other languages
English (en)
Spanish (es)
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Application granted granted Critical
Publication of AR230047A1 publication Critical patent/AR230047A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/24—Benzimidazoles; Hydrogenated benzimidazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D235/26—Oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
AR289500A 1981-05-26 1982-05-24 Procedimiento para obtener derivados heterociclicos de amidoximas AR230047A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8110428A FR2506767A1 (fr) 1981-05-26 1981-05-26 Derives heterocycliques d'amidoximes, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
AR230047A1 true AR230047A1 (es) 1984-02-29

Family

ID=9258896

Family Applications (1)

Application Number Title Priority Date Filing Date
AR289500A AR230047A1 (es) 1981-05-26 1982-05-24 Procedimiento para obtener derivados heterociclicos de amidoximas

Country Status (19)

Country Link
US (2) US4438121A (ja)
EP (1) EP0067094B1 (ja)
JP (1) JPS57206663A (ja)
AR (1) AR230047A1 (ja)
AT (1) ATE15894T1 (ja)
AU (1) AU550769B2 (ja)
CA (1) CA1185603A (ja)
DE (1) DE3266640D1 (ja)
DK (1) DK234182A (ja)
ES (1) ES8304086A1 (ja)
FI (1) FI821857A0 (ja)
FR (1) FR2506767A1 (ja)
GR (1) GR76445B (ja)
HU (1) HU186515B (ja)
IL (1) IL65876A (ja)
NO (1) NO821725L (ja)
NZ (1) NZ200729A (ja)
PT (1) PT74952B (ja)
ZA (1) ZA823628B (ja)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2506767A1 (fr) * 1981-05-26 1982-12-03 Synthelabo Derives heterocycliques d'amidoximes, leur preparation et leur application en therapeutique
FR2564461B1 (fr) * 1984-05-15 1986-09-19 Synthelabo Derives d'isoquinoleine, leur preparation et leurs applications
TW200643015A (en) * 2005-03-11 2006-12-16 Akzo Nobel Nv 2-(4-oxo-4H-quinazolin-3-yl)acetamide derivatives
CN101528703B (zh) * 2006-09-11 2011-09-07 欧加农股份有限公司 2-（1-氧代-1h-异喹啉-2-基）乙酰胺衍生物
EP2069315B1 (en) * 2006-09-11 2011-09-07 N.V. Organon Quinazolinone and isoquinolinone acetamide derivatives

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2425288A (en) * 1945-01-08 1947-08-05 Commercial Solvents Corp Plasticized butadiene polymer compositions containing phthalimidoalkyl alkanoates
US3291799A (en) 1964-09-21 1966-12-13 Hoffmann La Roche Isoquinoline carboxamidine
DE1670497C3 (de) 1967-06-06 1973-12-20 Chinoin Gyogyszer- Es Vegyeszeti Termekek Gyara Rt, Budapest Isochinohnderivate und Verfahren zu deren Herstellung
US3635974A (en) * 1968-12-20 1972-01-18 Boehringer Sohn Ingelheim Alpha-phenyl-2-aminomethyl-benzylalcohols and salts thereof
US3686184A (en) 1969-04-21 1972-08-22 Sterling Drug Inc 3,4-dihydro-2(1h)-isoquinolinecarboxamidoximes
US3658832A (en) * 1969-12-08 1972-04-25 American Cyanamid Co Novel antimicrobial nitroimidazolyl-1 2 4-oxadiazoles
US3654299A (en) * 1969-12-08 1972-04-04 American Cyanamid Co Nitroimidazolyl antimicrobial agents
US3795735A (en) * 1969-12-08 1974-03-05 American Cyanamid Co Antimicrobial nitroimidazolyl-1,2,4-oxadiazoles
FR2150590A1 (en) * 1971-08-27 1973-04-13 Ferlux N (2-phenyl-3-pyridayon-4-yl)piperalines - with analgesic antipyretic antiinflammatory and hypotensive activity
BE792182A (fr) * 1971-12-03 1973-06-01 Hoffmann La Roche 5-nitro-imidazoles
US3927000A (en) 1972-08-21 1975-12-16 Sterling Drug Inc 1(OR 3) Perfluoroalkyl-3,4-dihydro-2(1H)-isoquinolinecarbonitriles and intermediates
IL44350A0 (en) * 1973-04-05 1974-06-30 Sparamedica Ag New imidazole derivatives,their manufacture and pharmaceutical compositions containing them
US3984470A (en) 1974-01-15 1976-10-05 Labaz Amidoxime derivatives and process for preparing the same
FR2257273B1 (ja) 1974-01-15 1978-01-13 Labaz
GB1477607A (en) 1975-03-13 1977-06-22 Roche Products Ltd 2-amidino-4-hydroxy-1,2,3,4-tetrahydroisoquinoline and salts thereof
CH623971B5 (de) * 1976-06-04 1982-01-15 Hoechst Ag Verfahren zur herstellung neuer benzofuranderivate und deren verwendung als optische aufheller.
US4048176A (en) * 1976-07-23 1977-09-13 Morton-Norwich Products, Inc. 2-(3-Methyl-4-phenyl-1,2,3,4-tetrahydro-2-isoquinolyl)-acetamidoxime dihydrochloride
GB1602110A (en) * 1977-04-21 1981-11-04 Lafon Labor Acetamidoxime derivatives
US4265911A (en) 1979-10-09 1981-05-05 Synthelabo Propionamidoxime derivatives
FR2506767A1 (fr) * 1981-05-26 1982-12-03 Synthelabo Derives heterocycliques d'amidoximes, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
FR2506767A1 (fr) 1982-12-03
US4530843A (en) 1985-07-23
HU186515B (en) 1985-08-28
PT74952A (fr) 1982-06-01
FR2506767B1 (ja) 1984-02-10
DE3266640D1 (en) 1985-11-07
PT74952B (fr) 1985-05-16
ES512520A0 (es) 1983-02-16
IL65876A (en) 1985-09-29
JPS57206663A (en) 1982-12-18
NZ200729A (en) 1984-07-31
US4438121A (en) 1984-03-20
GR76445B (ja) 1984-08-10
ZA823628B (en) 1983-03-30
AU550769B2 (en) 1986-04-10
NO821725L (no) 1982-11-29
CA1185603A (en) 1985-04-16
JPS625423B2 (ja) 1987-02-04
IL65876A0 (en) 1982-08-31
ES8304086A1 (es) 1983-02-16
DK234182A (da) 1982-11-27
ATE15894T1 (de) 1985-10-15
EP0067094B1 (fr) 1985-10-02
AU8415782A (en) 1982-12-02
EP0067094A1 (fr) 1982-12-15
FI821857A0 (fi) 1982-05-25

Similar Documents

Publication Publication Date Title
AR231138A1 (es) Procedimiento para preparar derivados de 6(7)-oxiranil-metoxi-7(6)-metoxi o oxiranil-metoxi-quinazolina
ES528142A0 (es) Procedimiento para la obtencion de compuestos de hexapiranosa
ES496901A0 (es) Procedimiento para la fabricacion de derivados de la quino- lina
ES517332A0 (es) Procedimiento para preparar derivados de feniltiadiazinona.
ES525803A0 (es) Procedimiento para la obtencion de derivados de feniletilamina
AR231637A1 (es) Procedimiento para la preparacion de derivados substituidos de la piridazina
AR231537A1 (es) Procedimiento para la preparacion de derivados de la piridazina
AR231288A1 (es) Procedimiento para la preparacion de 3-amido-n-/2-5-dimetilaminometil-furan-2-il-metiltio etil-benzamidas
MX156087A (es) Procedimiento para la preparacion de derivados de piperazino-2-pirimidinas
ES515031A0 (es) Procedimiento para la obtencion de derivados de azolil-fenoxisustituidos.
MX157777A (es) Procedimiento para la preparacion de derivados de ascoclorina
ES549116A0 (es) Procedimiento para obtencion de derivados de flavolignano
MX5826E (es) Procedimiento para la obtencion de derivados de fenilimino metil-piridina
ES490987A0 (es) Procedimiento para la obtencion de nuevos aldehido-eteres alifaticos
AR230047A1 (es) Procedimiento para obtener derivados heterociclicos de amidoximas
ES500892A0 (es) Procedimiento para la obtencion de derivados de bifeni- lil-azoliletano
ES504787A0 (es) Procedimiento para la obtencion de derivados de diaril-imi- dazol
ES509744A0 (es) Procedimiento para preparar derivados sustituidos de tetrahidropirimidinona.
ES500959A0 (es) Procedimiento para la preparacion de derivados de cianoal- quil-fenilurea
ES497444A0 (es) Procedimiento para la obtencion de derivados de 2-amino-eta-nol
ES505206A0 (es) Procedimiento para la obtencion de derivados de 1-azolil-bu-tano fluorados
ES480637A0 (es) Procedimiento para la obtencion de nuevos derivados de la piperacina metanimina
ES509185A0 (es) Procedimiento para la obtencion de esteres de 4-fluor-3-halofenoxibencilo.
ES499421A0 (es) Procedimiento para preparar derivados de indano
AR229890A1 (es) Procedimiento para la preparacion de 1-carvona